Metronomic administration of the drug GMX1777, a cellular NAD synthesis inhibitor, results in neuroblastoma regression and vessel maturation without inducing drug resistance (Q43181029)
Jump to navigation
Jump to search
scientific article published in June 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Metronomic administration of the drug GMX1777, a cellular NAD synthesis inhibitor, results in neuroblastoma regression and vessel maturation without inducing drug resistance |
scientific article published in June 2010 |
Statements
1 reference
Metronomic administration of the drug GMX1777, a cellular NAD synthesis inhibitor, results in neuroblastoma regression and vessel maturation without inducing drug resistance (English)
1 reference
Dieter Fuchs
1 reference
Alejandro Rodriguez
1 reference
Sara Eriksson
1 reference
Rolf Christofferson
1 reference
Christian Sundberg
1 reference
Faranak Azarbayjani
1 reference
1 June 2010
1 reference
1 reference
126
1 reference
12
1 reference
2773-2789
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference